Surprisingly, anti-N(B.1) sera significantly reduced virus replication both in the upper and lower respiratory tract if the challenge dose was 4 lg, while in the case of 5 lg reduction in nasal viral titers compared to the mock group it did not reach statistical significance ( Figure 1 a,b).
← all excerpts
Protective Potential and Functional Role of Antibodies Against SARS-CoV-2 Nucleocapsid Protein.
1
—
—